News
Before diving deeper into the specifics of the Plex-Ginkgo partnership, it’s vital to understand how AI is reshaping the drug discovery process: The collaboration between Plex and Ginkgo ...
CAMBRIDGE, Mass., April 03, 2025--(BUSINESS WIRE)--Plex Research, a biotechnology company using autonomous artificial intelligence (AI) to aid in drug discovery, today announced that it is ...
Part of the partners' plan is to use Plex's AI to identify potential new uses for existing treatments that can be used to ...
Iwaoka began with a brief background of the Mahol-A-Ba platform, which, she explained, established a “Human-in-the-Loop” drug discovery process that integrates humans, AI, and robots.
Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is most impactful in the drug discovery marketplace: Drug discovery ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised external capital for the first time. The $600 million round was led by Thrive Capital ...
Despite issues with data quality and privacy, the use of AI in drug discovery has enormous potential to revolutionize the pharmaceutical sector by providing quicker, more accurate, and more ...
There is no denying that artificial intelligence (AI) has captured the imagination of innovators working across the pharmaceutical sector. The drug discovery space is no different, with myriad ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results